ERBB2 and breast cancer: In ERα- BC cell lines, NFkB is often found to be constitutively active, while its activation status is intermediate in ERα+/HER2+ BC cell lines; finally, a low or absent NFkB expression is typically found in ERα+/HER2 negative human BC cell lines [51].